| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/NNM.14.127 |
| P698 | PubMed publication ID | 25490427 |
| P2093 | author name string | Wei Li | |
| Jie Gao | |||
| Yajun Guo | |||
| Si-Shen Feng | |||
| Huafeng Wei | |||
| Huafei Li | |||
| P2860 | cites work | Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. | Q53275631 |
| Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine. | Q53514296 | ||
| siRNA Delivery into Human T Cells and Primary Cells with Carbon-Nanotube Transporters | Q56785863 | ||
| Cancer immunotherapy: moving beyond current vaccines | Q24548229 | ||
| Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy | Q27488746 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway | Q28216760 | ||
| The three Es of cancer immunoediting | Q28251475 | ||
| Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target | Q28266775 | ||
| Cancer immunotherapy | Q28306181 | ||
| Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study | Q29547366 | ||
| Drug resistance and the solid tumor microenvironment | Q29614403 | ||
| Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
| Immunological properties of engineered nanomaterials | Q29615634 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates | Q29620051 | ||
| Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 | ||
| Role of target geometry in phagocytosis | Q30477258 | ||
| Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation | Q33752783 | ||
| Immunology: improving on nature in the twenty-first century | Q33824735 | ||
| The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors | Q33837886 | ||
| Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy | Q33867281 | ||
| Chronic delivery of antibody fragments using immunoisolated cell implants as a passive vaccination tool | Q33886377 | ||
| Antigen-processing machinery breakdown and tumor growth | Q34011098 | ||
| The role of HER2 in cancer therapy and targeted drug delivery | Q34054213 | ||
| Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole. | Q34147085 | ||
| Novel dual-control poly(N-isopropylacrylamide-co-chlorophyllin) nanogels for improving drug release | Q34183165 | ||
| Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses | Q34802680 | ||
| Cancer vaccines: between the idea and the reality | Q35219026 | ||
| Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. | Q35749889 | ||
| Cancer vaccine development: on the way to break immune tolerance to malignant cells. | Q35879344 | ||
| Challenges facing adjuvants for cancer immunotherapy | Q35953773 | ||
| Multifunctional triblock copolymers for intracellular messenger RNA delivery | Q36140780 | ||
| Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma | Q36174230 | ||
| Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors | Q36197855 | ||
| Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
| Polymer conjugates as anticancer nanomedicines | Q36561667 | ||
| Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate | Q36692593 | ||
| Chemical adjuvants for plasmid DNA vaccines. | Q36756851 | ||
| Implication of nanoparticles/microparticles in mucosal vaccine delivery | Q36837152 | ||
| Targeted pharmaceutical nanocarriers for cancer therapy and imaging | Q36871933 | ||
| Particle-based vaccines for transcutaneous vaccination | Q36960310 | ||
| Nanoparticles and microparticles as vaccine-delivery systems | Q36968297 | ||
| Innovative strategies for co-delivering antigens and CpG oligonucleotides | Q37130626 | ||
| Virus-like particles as a vaccine delivery system: myths and facts. | Q37148127 | ||
| Recent progress in tumor pH targeting nanotechnology | Q37197375 | ||
| Role of particle size in phagocytosis of polymeric microspheres | Q37475631 | ||
| Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses | Q37607079 | ||
| Materials engineering for immunomodulation | Q37639157 | ||
| Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer | Q37653439 | ||
| Immune regulatory antibodies: are they the next advance? | Q37778691 | ||
| Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses | Q37785952 | ||
| Virus-like particles in vaccine development. | Q37798008 | ||
| Third generation dendritic cell vaccines for tumor immunotherapy | Q37858035 | ||
| Cancer immunotherapy--revisited | Q37908998 | ||
| Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know. | Q37909894 | ||
| Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment | Q37970682 | ||
| Tailoring polymeric micelles to optimize delivery to solid tumors | Q38038896 | ||
| The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy | Q38087360 | ||
| Monoclonal antibody-based therapies in cancer: advances and challenges | Q38090836 | ||
| Smart polymeric micelles for gene and drug delivery. | Q38225037 | ||
| Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab | Q39038492 | ||
| Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles | Q39357142 | ||
| Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro | Q39526886 | ||
| Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery | Q39587181 | ||
| Efficient delivery of bioactive antibodies into the cytoplasm of living cells by charge-conversional polyion complex micelles. | Q39731213 | ||
| Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface | Q39747863 | ||
| Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polycation chain-length | Q39781975 | ||
| Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology | Q39919528 | ||
| Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery | Q39980708 | ||
| Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells | Q40015848 | ||
| Opportunities and challenges in vaccine delivery | Q40020646 | ||
| Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity | Q40062912 | ||
| Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine | Q40091323 | ||
| Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer | Q40175088 | ||
| Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy | Q40217887 | ||
| T-cell growth factor | Q40293133 | ||
| Super pH-sensitive multifunctional polymeric micelle | Q40442115 | ||
| Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. | Q40453716 | ||
| A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex | Q40703521 | ||
| Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response | Q42799537 | ||
| Fully synthetic polymer vesicles for intracellular delivery of antibodies in live cells | Q42830036 | ||
| Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. | Q43012213 | ||
| Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles | Q43466579 | ||
| Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers | Q44026880 | ||
| Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity | Q44906742 | ||
| Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers | Q45228621 | ||
| Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells | Q45413835 | ||
| Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation | Q45767689 | ||
| Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles | Q46162395 | ||
| Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice | Q46380155 | ||
| PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. | Q46657736 | ||
| The control of dendritic cell maturation by pH-sensitive polyion complex micelles. | Q47299282 | ||
| Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination | Q47790870 | ||
| Polymeric nanoparticulates for cancer immunotherapy. | Q51010788 | ||
| Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. | Q51011425 | ||
| Direct evaluation of DLVO theory for predicting long-range forces between a yeast cell and a surface. | Q51368452 | ||
| Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. | Q51997055 | ||
| Oncogene addiction. | Q52300193 | ||
| P433 | issue | 16 | |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | 2587-2605 | |
| P577 | publication date | 2014-11-01 | |
| P1433 | published in | Nanomedicine | Q15817508 |
| P1476 | title | Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology | |
| P478 | volume | 9 |
| Q35649616 | A redox-sensitive micelle-like nanoparticle self-assembled from amphiphilic adriamycin-human serum albumin conjugates for tumor targeted therapy |
| Q50885932 | Lysosome-dependent necrosis specifically evoked in cancer cells by gold nanorods. |
| Q36038911 | Lysosome-mitochondria-mediated apoptosis specifically evoked in cancer cells induced by gold nanorods |
| Q38603362 | Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells |
| Q52915318 | Nanotechnology-Based Cancer Vaccine. |
| Q33758385 | Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle. |
| Q36217155 | Synergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity |
| Q55338907 | The crucial roles of inflammatory mediators in inflammation: A review. |
| Q38658279 | Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies |
Search more.